Latest Articles
Broker’s call: NMDC (Buy) – The Hindu BusinessLine
Target: ₹180 CMP:₹150.20 We upgrade NMDC to Buy from Add as sales volume in FY24 may breach the 32-40 mt range; long-term volume visibility is clearer as the roadmap for 100 mtpa by FY30, though …
Building Your Corporate Empire: Legendary Strategies for Dominance!
Dive into the profound intersection of Sunzi's timeless teachings from 'The Art of War' and modern financial strategies. From understanding the intricate investment landscape to crafting holistic financial plans, this book offers insights into ethical finance, wealth protection, and market volatilities. Drawing parallels between military tactics and financial decision-making, it explores the importance of ethical investments, the power of market intelligence, and the significance of legacy planning. Whether you're a seasoned investor or a financial novice, discover how Sunzi's ancient wisdom can guide you towards informed, strategic, and ethical financial decisions in today's dynamic financial realm.
Nifty hits fresh record; Sensex extends rally for 10th day
The NSE benchmark Nifty advanced over 33 points to close at a fresh lifetime high of 20,103 while Sensex ticked higher for the tenth straight session on Thursday, helped by fag-end buying in oil & …
India’s edible oil imports up 26.23% since November 2022
A sharp drop in domestic prices in August boosted demand for edible oil, leading to an increase in imports. Data compiled by Solvent Extractors’ Association of India (SEA) showed that India imported 18.52 lakh tonnes …
Hi-Green Carbon IPO GMP, Review, Price, Allotment
Hi-Green Carbon IPO description – Incorporated in 2011, Hi-Green Carbon is engaged in the business of waste tyres recycling. The company’s manufacturing plant is located in Rajasthan. The plant operates on a continuous pyrolysis process. It …
Sun Pharma partners with Pharmazz Inc. for stroke treatment
Sun Pharmaceutical Industries Limited announced a licensing agreement between one of its wholly-owned subsidiaries and Pharmazz Inc., a U.S. biopharmaceutical company. The collaboration aims to introduce Sovateltide, an innovative drug designed to treat acute cerebral …





